欢迎来到联参智库! | 帮助中心 联合作战情报参考网
联参智库

非专利

The Generic Drug User Fee Amendments GDUFA: Background and Reauthorization April 29, 2021 Congressional Research Servic, https:crsreports.congress.go

非专利Tag内容描述:

1、 The Generic Drug User Fee Amendments GDUFA: Background and Reauthorization April 29, 2021 Congressional Research Servic。

2、 https:crsreports.congress.gov January 17, 2019FDA and Drug Prices: Facilitating Access to Generic Drugs A variety of pr。

3、 https:crsreports.congress.gov October 31, 2016Risk Evaluation and Mitigation Strategies REMS and Generic DrugsBackgroun。

4、CRS Report for CongressPrepared for Members and Committees of Congress Authorized Generic Pharmaceuticals: Effects on In。

5、CRS Report for CongressPrepared for Members and Committees of Congress Proposed FDA User Fee Acts: Generic Drug User Fee。

【非专利】相关PDF文档
[20210429]R46778_非专利药物使用者费用修正案(GDUFA):背景和重新授权.pdf
[20190117]IF11075_FDA和药品价格:促进获得非专利药物 .pdf
[20161031]IF10494_风险评估和缓解策略(REMS)和非专利药物.pdf
[20130117]RL33605_授权非专利药品:对创新的影响.pdf
1

客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



联参智库